LoginRegister
    Tarapur facility receives EIR from US FDA: LupinTarapur facility receives EIR from US FDA: Lupin
    Loxo,Bayer gets U.S approval for cancer drug LarotrectinibLoxo,Bayer gets U.S approval for cancer drug Larotrectinib
    Sun Pharma to acquire JapanSun Pharma to acquire Japan's Pola Pharma for Rs 7 crores approx
    ICIJ Implant Files: Medtronic allegedly linked to many breachesICIJ Implant Files: Medtronic allegedly linked to many breaches
    Alembic Pharmaceuticals gets USFDA nod for pain relief ointment -XylocaineAlembic Pharmaceuticals gets USFDA nod for pain relief ointment -Xylocaine
    Sun Pharmaceutical, subsidiary enter settlements in Modafinil antitrust litigationSun Pharmaceutical, subsidiary enter settlements in Modafinil antitrust litigation
    Lupin gets USFDA nod generic Clomipramine Hydrochloride capsulesLupin gets USFDA nod generic Clomipramine Hydrochloride capsules
    Merck appoints Jasper Bos as Managing Director of venture capital arm M VenturesMerck appoints Jasper Bos as Managing Director of venture capital arm M Ventures
    Indian biosimilar market to be worth USD 40 billion by 2030: CII reportIndian biosimilar market to be worth USD 40 billion by 2030: CII report
    Glenmark Pharma gets tentative USFDA nod for Clobetasol Propionate foam to treat Skin ailmentsGlenmark Pharma gets tentative USFDA nod for Clobetasol Propionate foam to treat Skin ailments
    U.S. benefits manager baulks after Novartis values gene therapy at $4-5 millionU.S. benefits manager baulks after Novartis values gene therapy at $4-5 million
    Pricing might be tested with costly eye therapy: NovartisPricing might be tested with costly eye therapy: Novartis
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X